: Foghorn Therapeutics started at outperform with $20 stock price target at BMO Capital

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.

Best Stock Market Signals
Futures Trading
Stock Trading
Stock Trading Signals

Cart

: Foghorn Therapeutics started at outperform with $20 stock price target at BMO Capital | Best Stock Trading Signals

admin

previous: Ford December EV sales up 222.6% from a year ago to 7,823 vehicles

next: Peloton to pay $19.1 mln civil penalty related to Tread+ recall — CPSC

<div>Final S&P U.S. manufacturing index is 52.2 in February vs. initial 51.5</div>

Duolingo started at buy with $222 price target at Seaport

Home builders sentiment index rises in February to 48 vs forecast of 46